Yuki Tomizawa
age ~49
from Jersey City, NJ
Yuki Tomizawa Phones & Addresses
- 20 Newport Pkwy APT 2708, Jersey City, NJ 07310
- 252 Old Post Rd, Edison, NJ 08817 • 732-985-3475
- Huntington Beach, CA
- Metuchen, NJ
- New York, NY
- 5 Redfield Vlg #B, Metuchen, NJ 08840 • 732-767-1477
Work
-
Company:Ptc therapeutics, incFeb 2009
-
Position:Associate scientist ii
Education
-
School / High School:Northeastern University- Boston, MA2009
-
Specialities:M.S. in Drugs, Biologics and Medical Devices
Skills
TECHNICAL BACKGROUND Drug Discovery: ... • cDNA • site-directed mutagenesis of cDNA • and RACE) RT-PCR • quantitative real-time PCR • and Cells - to - Ct RNA determination D...
Us Patents
-
Methods Of Screening For Compounds For Treating Muscular Dystrophy Using Utrn Mrna Translation Regulation
view source -
US Patent:8283115, Oct 9, 2012
-
Filed:Jun 20, 2008
-
Appl. No.:12/143705
-
Inventors:Westley J Friesen - Huntingdon Valley PA, US
Nikolai Naryshkin - East Brunswick NJ, US
Meenal Patel - Fairless Hills PA, US
Charles Romfo - Easton PA, US
Ellen Welch - Califon NJ, US
Yuki Tomizawa - Edison NJ, US
Jin Zhuo - Belle Mead NJ, US -
Assignee:PTC Therapeutics, Inc. - South Plainfield NJ
-
International Classification:C12Q 1/68
-
US Classification:435 6
-
Abstract:The present invention provides compounds and assays for the identification and validation of compounds for use in the treatment of muscular dystrophy (MD), or a form thereof, in which said compounds increase the post-transcriptional expression of a target gene (i. e. , mIGF1, ITGA7, or UTRN).
-
Methods For Treating Epilepsy
view source -
US Patent:20200188362, Jun 18, 2020
-
Filed:Nov 7, 2019
-
Appl. No.:16/676806
-
Inventors:- South Plainfield NJ, US
Yuki Tomizawa - Jersey City NJ, US
Priya Vazirani - South Amboy NJ, US -
Assignee:PTC Therapeutics, Inc. - South Plainfield NJ
-
International Classification:A61K 31/4245
A61P 25/08
A61K 31/535 -
Abstract:Provided herein are methods of treating, preventing, ameliorating or managing a nonsense mutation mediated epileptic disease, comprising administering a 1,2,4-oxadiazole benzoic acid to a patient having a nonsense mutation mediated epileptic disease. In particular, provided herein are methods of treating, preventing, ameliorating or managing a CDKL5 and/or SCN1A (Dravet syndrome) nonsense mutation mediated epileptic disease.
-
Methods For Treating Epilepsy
view source -
US Patent:20180333397, Nov 22, 2018
-
Filed:Oct 28, 2016
-
Appl. No.:15/771379
-
Inventors:- South Plainfield NJ, US
Yuki Tomizawa - Jersey City NJ, US
Priya Vazirani - South Amboy NJ, US -
Assignee:PTC Therapeutics, Inc. - South Plainfield NJ
-
International Classification:A61K 31/4245
A61P 25/08 -
Abstract:Provided herein are methods of treating, preventing, ameliorating or managing a nonsense mutation mediated epileptic disease, comprising administering a 1,2,4-oxadiazole benzoic acid to a patient having a nonsense mutation mediated epileptic disease. In particular, provided herein are methods of treating, preventing, ameliorating or managing a CDKL5 and/or SCN1A (Dravet syndrome) nonsense mutation mediated epileptic disease.
Resumes
Yuki Tomizawa Jersey City, NJ
view sourceWork:
PTC Therapeutics, Inc
Feb 2009 to 2000
Associate Scientist II PTC Therapeutics, Inc.
South Plainfield, NJ
Feb 2006 to Jan 2009
Associate Scientist I PTC Therapeutics, Inc.
South Plainfield, NJ
Oct 2000 to Jan 2006
Research Associate II PTC Therapeutics, Inc.
South Plainfield, NJ
Oct 2000 to Sep 2001
Research Associate I University of Medicine and Dentistry of New Jersey (UMDNJ)
Piscataway, NJ
Sep 2000 to Oct 2000
Senior Laboratory Technician University of Medicine and Dentistry of New Jersey (UMDNJ)
Piscataway, NJ
May 2000 to Aug 2000
Laboratory Assistant University of Medicine and Dentistry of New Jersey (UMDNJ)
Piscataway, NJ
May 1998 to Apr 2000
Student Assistant
Feb 2009 to 2000
Associate Scientist II PTC Therapeutics, Inc.
South Plainfield, NJ
Feb 2006 to Jan 2009
Associate Scientist I PTC Therapeutics, Inc.
South Plainfield, NJ
Oct 2000 to Jan 2006
Research Associate II PTC Therapeutics, Inc.
South Plainfield, NJ
Oct 2000 to Sep 2001
Research Associate I University of Medicine and Dentistry of New Jersey (UMDNJ)
Piscataway, NJ
Sep 2000 to Oct 2000
Senior Laboratory Technician University of Medicine and Dentistry of New Jersey (UMDNJ)
Piscataway, NJ
May 2000 to Aug 2000
Laboratory Assistant University of Medicine and Dentistry of New Jersey (UMDNJ)
Piscataway, NJ
May 1998 to Apr 2000
Student Assistant
Education:
Northeastern University
Boston, MA
2009 to 2011
M.S. in Drugs, Biologics and Medical Devices The State University of New Jersey
Piscataway, NJ
Sep 1998 to May 2000
B.A. in Biological Sciences The City University of New York
New York, NY
Sep 1996 to Aug 1998
Biological Sciences
Boston, MA
2009 to 2011
M.S. in Drugs, Biologics and Medical Devices The State University of New Jersey
Piscataway, NJ
Sep 1998 to May 2000
B.A. in Biological Sciences The City University of New York
New York, NY
Sep 1996 to Aug 1998
Biological Sciences
Skills:
TECHNICAL BACKGROUND Drug Discovery: Molecular Biology Cloning (genomic DNA, cDNA, site-directed mutagenesis of cDNA, and RACE) RT-PCR, quantitative real-time PCR, and Cells - to - Ct RNA determination DNA and RNA purification Northern blotting Protein purification (recombinant protein) Western blot Enzyme assay in vitro translation assay Primer extension and DNA sequence analysis Chemical footprinting Cell Biology Construction of stable cell lines Cell based reporter gene assay Apoptosis and cell death assay Immunology Meso Scale Discovery formatted ELISA (both cells and tissue samples) ELISA Fluorescence microscopy (immunofluorescence) Immunohistochemistry
Yuki Tomizawa
view source
Yuki Tomizawa
view sourceFriends:
Leon Donegan, Mario Alfonso Gonzalez Martinez, Siobhn Mary Hoy
Yuki Tomizawa
view sourceYoutube
Googleplus
Yuki Tomizawa
Yuki Tomizawa
Get Report for Yuki Tomizawa from Jersey City, NJ, age ~49